Skip to main navigation Skip to search Skip to main content

Ntrust-2: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy in Subjects with Immune-Mediated Diseases

    Project: Research

    Project Details

    StatusActive
    Effective start/end date05/5/25 → …